Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Ikapharmindo Putramas Tbk. (IKPM) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Ikapharmindo Putramas Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Ikapharmindo Putramas Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Ikapharmindo Putramas Tbk. trades at Rp196 (market cap 333.56B, 96.7K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. and Ikapharmindo Putramas Tbk. are close in size by market cap, and Ikapharmindo Putramas Tbk. is more actively traded (96.7K versus 41.7K). Which is the better fit depends on your goals.

DGNSIKPM
Market Cap
316.25B333.56B
Volume
41.7K96.7K
Lot
417967
Turnover
9.66M19.03M
Average Price
231.65196.81
Value
9.66M19.03M
Indicative Equilibrium Price
230
Indicative Equilibrium Volume
2.4K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
IKPM
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Ikapharmindo Putramas Tbk.

PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.

Read more on IKPM